Midwest Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$425K Buy
9,963
+114
+1% +$6.19K ﹤0.01% 478
2026
Q1
$618K Sell
9,849
-266
-3% -$21.3K 0.01% 406
2025
Q4
$964K Sell
10,115
-2
-0% -$196 0.01% 343
2025
Q3
$988K Buy
10,117
+1,568
+18% +$162K 0.01% 347
2025
Q2
$918K Buy
+8,549
New +$865K 0.01% 351

Other funds holding BSX

Midwest Trust's BSX Position: Q2 2026 in Review

Midwest Trust increased its Boston Scientific (BSX) stake by 1.2% in Q2 2026, buying an estimated $6.19K and bringing the position to 9,963 shares worth $425K. The position accounts for ﹤0.01% of the portfolio, ranked #478.

Midwest Trust first reported a position in BSX in Q2 2025 and has held it in 5 quarters since. The position peaked at $988K in Q3 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Midwest Trust held 9,963 shares of Boston Scientific worth $425K as of Q2 2026.
  • Midwest Trust bought 114 Boston Scientific shares in Q2 2026, an estimated $6.19K.
  • Boston Scientific made up ﹤0.01% of Midwest Trust's portfolio in Q2 2026, its #478 holding.
  • Midwest Trust first reported a position in Boston Scientific in Q2 2025 and has held it in 5 quarters since.
  • Midwest Trust's Boston Scientific position peaked at $988K in Q3 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.